These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 14499684

  • 1. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis.
    Kwak C, Kim HK, Kim EC, Choi MS, Kim HH.
    Eur Urol; 2003 Oct; 44(4):475-81. PubMed ID: 14499684
    [Abstract] [Full Text] [Related]

  • 2. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA, Sidhu H, Kaul P, Low RK.
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [Abstract] [Full Text] [Related]

  • 3. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India.
    Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD.
    Eur Urol; 2002 Mar; 41(3):318-22. PubMed ID: 12180235
    [Abstract] [Full Text] [Related]

  • 4. Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis.
    Mittal RD, Kumar R.
    J Endourol; 2004 Jun; 18(5):418-24. PubMed ID: 15253809
    [Abstract] [Full Text] [Related]

  • 5. Development of an Innovative Method by Optimizing qPCR Technique for Isolating and Determining Oxalobacter Formigenes Microbial Load in the Stool of Patients with Urolithiasis.
    Jafari GA, Fotouhi Ardakani R, Akhavan Sepahi M, Nowroozi J, Soltanpour MS.
    Iran J Kidney Dis; 2021 May; 15(3):190-198. PubMed ID: 33994378
    [Abstract] [Full Text] [Related]

  • 6. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A.
    Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
    [Abstract] [Full Text] [Related]

  • 7. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P, Niedźwiadek J, Mazur E, Paluch-Oleś J, Zajaczkowska M, Kozioł-Montewka M.
    Arch Med Res; 2009 Jul; 40(5):369-73. PubMed ID: 19766900
    [Abstract] [Full Text] [Related]

  • 8. Molecular identification of Oxalobacter formigenes with the polymerase chain reaction in fresh or frozen fecal samples.
    Kwak C, Jeong BC, Lee JH, Kim HK, Kim EC, Kim HH.
    BJU Int; 2001 Oct; 88(6):627-32. PubMed ID: 11678762
    [Abstract] [Full Text] [Related]

  • 9. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
    Gnanandarajah JS, Abrahante JE, Lulich JP, Murtaugh MP.
    Urol Res; 2012 Oct; 40(5):467-73. PubMed ID: 22223029
    [Abstract] [Full Text] [Related]

  • 10. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S, von Unruh GE, Watson ID, Laube N, Willets S, Soni BL.
    ScientificWorldJournal; 2006 Apr 06; 6():2403-10. PubMed ID: 17619709
    [Abstract] [Full Text] [Related]

  • 11. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.
    Batislam E, Yilmaz E, Yuvanc E, Kisa O, Kisa U.
    Urol Res; 2012 Oct 06; 40(5):455-60. PubMed ID: 22215293
    [Abstract] [Full Text] [Related]

  • 12. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A.
    BJU Int; 2020 Jan 06; 125(1):133-143. PubMed ID: 31145528
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW, Choy D, Penniston KL, Lange D.
    Kidney Int; 2019 Jul 06; 96(1):180-188. PubMed ID: 31130222
    [Abstract] [Full Text] [Related]

  • 14. Variability of Oxalobacter formigenes and oxalate in stool samples.
    Prokopovich S, Knight J, Assimos DG, Holmes RP.
    J Urol; 2007 Nov 06; 178(5):2186-90. PubMed ID: 17870112
    [Abstract] [Full Text] [Related]

  • 15. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
    Kumar R, Ghoshal UC, Singh G, Mittal RD.
    J Gastroenterol Hepatol; 2004 Dec 06; 19(12):1403-9. PubMed ID: 15610315
    [Abstract] [Full Text] [Related]

  • 16. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB.
    J Am Soc Nephrol; 1999 Nov 06; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [Abstract] [Full Text] [Related]

  • 17. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
    Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M.
    Med Princ Pract; 2003 Nov 06; 12(4):208-13. PubMed ID: 12966191
    [Abstract] [Full Text] [Related]

  • 18. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A.
    Am J Kidney Dis; 2005 Sep 06; 46(3):440-5. PubMed ID: 16129205
    [Abstract] [Full Text] [Related]

  • 19. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion.
    Jiang J, Knight J, Easter LH, Neiberg R, Holmes RP, Assimos DG.
    J Urol; 2011 Jul 06; 186(1):135-9. PubMed ID: 21575973
    [Abstract] [Full Text] [Related]

  • 20. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria.
    Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB.
    Lancet; 1998 Sep 26; 352(9133):1026-9. PubMed ID: 9759746
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.